US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Blossomhill Therapeutics Inc

19.69

+1.105.92%

Post-market: 19.690.00000.00%19:30 EDT

Volume:169.33K

Turnover:3.27M

Market Cap:625.84M

PE:-8.06

High:19.86

Open:18.33

Low:18.27

Close:18.59

52wk High:27.99

52wk Low:15.25

Shares:31.78M

Float Shares:9.38M

Volume Ratio:0.77

T/O Rate:1.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.4440

EPS(LYR):-24.8342

ROE:--

ROA:--

PB:-3.58

PE(LYR):-0.79

Loading ...

Overview Company News Filings

BlossomHill Therapeutics to Present Updated Phase 1/2 Solara Trial Data on BH-30643 in EGFR-Mutant NSCLC at WCLC 2026

BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer

BlossomHill Therapeutics Price Target Announced at $35.00/Share by HC Wainwright & Co.

BlossomHill Therapeutics initiated with an Outperform at LifeSci Capital

BlossomHill Therapeutics initiated with a Buy at Guggenheim

Blossomhill Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $35

THOMSON REUTERS

BlossomHill Therapeutics initiated with an Overweight at JPMorgan

U.S. Research Roundup-Autodesk, Hubspot, Oracle

Blossomhill Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Target Price $28

THOMSON REUTERS

Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday

MT Newswires Live

BlossomHill Says BH-30643 Gets FDA Fast Track Designation in Non-Small Cell Lung Cancer

MT Newswires Live

BlossomHill Therapeutics receives fast track designation for BH-30643 from FDA

Blossomhill Therapeutics Announces FDA Fast Track Designation for Bh-30643, a Macrocyclic Omni-Egfr™ Inhibitor for the Treatment of Advanced Egfr C797s-Positive Nsclc

THOMSON REUTERS

Major Insider Buying Spree Signals Big Confidence in This Biotech Stock

OrbiMed Advisors Acquires $10 Million of BlossomHill Therapeutics Common Shares

BlossomHill Leaders Go All-In With Bold Insider Buying Spree

BlossomHill Therapeutics General Counsel Vincent Paul Liptak Buys USD 74,300 of Common Shares

BlossomHill Therapeutics Adopts Amended, Restated Bylaws Ahead of IPO Close

BlossomHill Therapeutics Shares Fall in Nasdaq Debut

MT Newswires Live

U.S. Stocks on the MOVE-Atlassian, Macerich, DoubleVerify

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BLSM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BLSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","market":"US","secType":"STK","nameCN":"Blossomhill Therapeutics Inc","latestPrice":19.69,"timestamp":1790971200000,"preClose":18.59,"halted":0,"volume":169327,"hourTrading":{"tag":"盘后","latestPrice":19.69,"preClose":19.69,"latestTime":"19:30 EDT","volume":564,"amount":11105.84,"timestamp":1790983804888,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.059171597633136175,"floatShares":9375000,"shares":31784899,"eps":-2.444,"marketStatus":"Market Closed","change":1.1,"latestTime":"10-02 16:00:00 EDT","open":18.33,"high":19.86,"low":18.27,"amount":3268778.3206370003,"amplitude":0.08553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.444,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":18.59,"preHourTrading":{"tag":"盘前","latestPrice":18.75,"preClose":18.59,"latestTime":"08:10 EDT","volume":152,"amount":2850.7499679999996,"timestamp":1790943053506,"change":0.16,"changeRate":0.008607,"amplitude":0.021517},"postHourTrading":{"tag":"盘后","latestPrice":19.69,"preClose":19.69,"latestTime":"19:30 EDT","volume":564,"amount":11105.84,"timestamp":1790983804888,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.774804},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","floatShares":9375000,"roa":"--","roe":"--","lyrEps":-24.834182,"volumeRatio":0.774804,"shares":31784899,"dividePrice":0,"high":19.86,"amplitude":0.08553,"preClose":18.59,"low":18.27,"week52Low":15.25,"pbRate":"-3.58","week52High":27.99,"institutionHeld":0,"latestPrice":19.69,"eps":-2.444,"divideRate":0,"volume":169327,"delay":0,"ttmEps":-2.444,"open":18.33,"prevYearClose":16,"prevWeekClose":19.75,"prevMonthClose":18.64,"prevQuarterClose":18.64,"fiveDayClose":19.75,"twentyDayClose":20.02,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLSM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLSM","date":"2026-10-01","current":-8.056465,"percent":0.641026,"low":-11.561693,"twenty":-9.482674,"median":-8.079945,"eighty":-6.974089,"high":-2.788792,"avg":-8.178508,"sd":1.555666,"marketCap":592470703},"quantilePoints":[{"date":"2026-08-07","current":-6.897356,"twenty":-6.075643,"median":-4.843074,"eighty":-3.610505,"marketCap":490298560},{"date":"2026-08-14","current":-7.048236,"twenty":-7.038752,"median":-6.897356,"eighty":-6.893907,"marketCap":501023841},{"date":"2026-08-21","current":-6.811139,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"marketCap":484169828},{"date":"2026-08-28","current":-8.535478,"twenty":-7.10945,"median":-6.974951,"eighty":-6.897356,"marketCap":606744468},{"date":"2026-09-04","current":-8.630317,"twenty":-8.140605,"median":-7.054702,"eighty":-6.899943,"marketCap":613486073},{"date":"2026-09-11","current":-9.272633,"twenty":-8.535478,"median":-7.091344,"eighty":-6.910289,"marketCap":659145126},{"date":"2026-09-18","current":-11.561693,"twenty":-9.371783,"median":-7.940581,"eighty":-6.940465,"marketCap":821862961},{"date":"2026-09-25","current":-7.973591,"twenty":-9.483865,"median":-8.079945,"eighty":-6.970641,"marketCap":650637087},{"date":"2026-10-01","current":-7.260759,"twenty":-9.482674,"median":-8.079945,"eighty":-6.974089,"marketCap":592470703}],"updateTime":1790982857200},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLSM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664537848","title":"BlossomHill Therapeutics to Present Updated Phase 1/2 Solara Trial Data on BH-30643 in EGFR-Mutant NSCLC at WCLC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664537848","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664537848?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:03","pubTimestamp":1788260634,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics to present updated Phase 1/2 SOLARA trial data on BH-30643 in EGFR-mutant NSCLC at WCLC 2026BlossomHill flagged updated Phase 1/2 SOLARA data for BH-30643 in EGFR-mutant NSCLC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL406lNH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","BLSM","IE00BQXX3C00.GBP","IE00BKPKM429.USD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3D17.EUR","BCDF","SG9999014039.USD","BK4588","SG9999014005.SGD","BK4112","BK4007","NDAQ","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853002","title":"BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853002","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853002?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"Data to be presented in a mini-oral session will describe anti-tumor activity of BH-30643 in patients with secondary EGFR resistance mutations such as EGFR C797S BH-30643 was recently granted Fast Tra","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353953/0/en/blossomhill-therapeutics-to-present-updated-data-from-ongoing-phase-1-2-solara-trial-of-its-macrocyclic-omni-egfr-inhibitor-bh-30643-in-egfr-mutant-nsclc-at-the-2026-world-conferen.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664853384","title":"BlossomHill Therapeutics Price Target Announced at $35.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664853384","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664853384?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:42","pubTimestamp":1788259320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLSM/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664538998","title":"BlossomHill Therapeutics initiated with an Outperform at LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2664538998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664538998?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:20","pubTimestamp":1788258014,"startTime":"0","endTime":"0","summary":"LifeSci Capital initiated coverage of BlossomHill Therapeutics (BLSM) with an Outperform rating and $32 price target Published first on TheFly – th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664585863","title":"BlossomHill Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2664585863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664585863?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:15","pubTimestamp":1788257708,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of BlossomHill Therapeutics (BLSM) with a Buy rating and $30 price target Published first on TheFly – the ultimate so...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664079830","title":"Blossomhill Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2664079830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664079830?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:09","pubTimestamp":1788257370,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nAZN4THM76:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830860","title":"BlossomHill Therapeutics initiated with an Overweight at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830860?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:30","pubTimestamp":1788255015,"startTime":"0","endTime":"0","summary":"JPMorgan initiated coverage of BlossomHill Therapeutics (BLSM) with an Overweight rating and $28 price target BlossomHill is a clinical-stage oncol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-initiated-with-an-overweight-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664836727","title":"U.S. Research Roundup-Autodesk, Hubspot, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2664836727","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664836727?lang=en_us&edition=fundamental","pubTime":"2026-09-01 15:06","pubTimestamp":1788246377,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, OracleSept 1 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk, Hubspot an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKAM","DBI","ARCC","EGP","CDP","CSCO","DUOL","BXP","VGT","ANNX","BLSM","CLOD","CPT","DASX","CTRE","A","AMAT","DASH","ABNB","ACRS","SAAPLmain","BILL","CSCS","COHR","VT","ASMB","ADBE","BBIO","BKNU","DELL","ATEN","DK","RDVI","WLDR","WNDR","CRWD","AAPL","CR","BXSL","DHR","ANET","ADSK","DRI","TXG","BKNG","CSR","BWA","BAH","CAPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664722880","title":"Blossomhill Therapeutics Inc : JP Morgan Initiates Coverage with Overweight Rating; Target Price $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2664722880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664722880?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:17","pubTimestamp":1788236270,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S0QQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660609344","title":"Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2660609344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660609344?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:17","pubTimestamp":1787059061,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to higher premarket Tuesday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 0.7%.Amylyx Pharm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","BK4588","BK4137","IMTX","LABU","BK4581","BK4007","LU0128526141.USD","LU0029874061.USD","BK4585","XLV","HCSG","AMLX","XBI","BK4139","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446439","title":"BlossomHill Says BH-30643 Gets FDA Fast Track Designation in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446439","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660446439?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:30","pubTimestamp":1787052613,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics (BLSM) said Tuesday the US Food and Drug Administration has granted fast track designation for BH-30643 in advanced or metastatic epidermal growth factor receptor C797S-positi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BH","BLSM","LABU","BK4588","BK4209","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461071","title":"BlossomHill Therapeutics receives fast track designation for BH-30643 from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461071?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:10","pubTimestamp":1787051413,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics (BLSM) announced that the FDA has granted fast track designation to BH-30643 for the treatment of adult patients with adva...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-receives-fast-track-designation-for-bh-30643-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-receives-fast-track-designation-for-bh-30643-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4209","BK4585","BH","BK4588","LENZ","BLSM","BK4007","BK4139","BK4539","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461682","title":"Blossomhill Therapeutics Announces FDA Fast Track Designation for Bh-30643, a Macrocyclic Omni-Egfr™ Inhibitor for the Treatment of Advanced Egfr C797s-Positive Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461682?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:00","pubTimestamp":1787050800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUACDWHCV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659018265","title":"Major Insider Buying Spree Signals Big Confidence in This Biotech Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2659018265","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659018265?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:02","pubTimestamp":1786586574,"startTime":"0","endTime":"0","summary":"New insider activity at BlossomHill Therapeutics, Inc. ( ($BLSM) ) has taken place on August 12, 2026. BlossomHill Therapeutics, Inc. has attracted...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-buying-spree-signals-big-confidence-in-this-biotech-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-buying-spree-signals-big-confidence-in-this-biotech-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SHAP.U","BK4581","BK4588","BLSM","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659618895","title":"OrbiMed Advisors Acquires $10 Million of BlossomHill Therapeutics Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659618895","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659618895?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:44","pubTimestamp":1786567481,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors acquires $10 million of BlossomHill Therapeutics common sharesOrbiMed Advisors reported a higher stake in Blossomhill Therapeutics, ending with 2,714,279 shares of common stock held i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLc8Txbg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"OrbiMed Advisors Acquires $10 Million of BlossomHill Therapeutics Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658965425","title":"BlossomHill Leaders Go All-In With Bold Insider Buying Spree","url":"https://stock-news.laohu8.com/highlight/detail?id=2658965425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658965425?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:02","pubTimestamp":1786413731,"startTime":"0","endTime":"0","summary":"New insider activity at BlossomHill Therapeutics, Inc. ( ($BLSM) ) has taken place on August 10, 2026. BlossomHill Therapeutics, Inc. has seen a no...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/blossomhill-leaders-go-all-in-with-bold-insider-buying-spree-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/blossomhill-leaders-go-all-in-with-bold-insider-buying-spree-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SHAP.U","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658166957","title":"BlossomHill Therapeutics General Counsel Vincent Paul Liptak Buys USD 74,300 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658166957","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658166957?lang=en_us&edition=fundamental","pubTime":"2026-08-11 06:26","pubTimestamp":1786400800,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics General Counsel Vincent Paul Liptak buys USD 74,300 of common sharesBlossomHill Therapeutics General Counsel Vincent Paul Liptak increased his direct stake to 111,412 common s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL4sL0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BlossomHill Therapeutics General Counsel Vincent Paul Liptak Buys USD 74,300 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658560419","title":"BlossomHill Therapeutics Adopts Amended, Restated Bylaws Ahead of IPO Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2658560419","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658560419?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392338,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics adopts amended, restated bylaws ahead of IPO closeBlossomhill Therapeutics adopted amended and restated bylaws effective Aug. 10, 2026, tied to the closing of its IPO.The comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL32V0JY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657235986","title":"BlossomHill Therapeutics Shares Fall in Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2657235986","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657235986?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:34","pubTimestamp":1786127660,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics  shares fell 2.3% to $15.63 in their Nasdaq debut on Friday.The stock opened at $15.75 and reached $16 before trading as low as $15.25.The company priced its upsized initial public offering of 9.375 million common shares at $16 each, raising $150 million in gross proceeds.The underwriters were granted a 30-day option to buy up to an additional 1.4 million shares.The offering is expected to close Monday.Price: 15.63, Change: -0.37, Percent Change: -2.31","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","LCLG","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657401316","title":"U.S. Stocks on the MOVE-Atlassian, Macerich, DoubleVerify","url":"https://stock-news.laohu8.com/highlight/detail?id=2657401316","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657401316?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:39","pubTimestamp":1786120748,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Atlassian, Macerich, DoubleVerifyAug 7 (Reuters)-Wall Street's main indexes were on track for strong weekly gains on Friday after data showed the U.S. economy unexpectedly","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL6N4440XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAC","COHR","VST","NET","WEAV","DV","DOCS","RUN","STX","BLSM","YJ","BNL","TEAM","REPL","VATE","FSLR","WEN","TTWO","ASIX","ATGL","SG","UAA","RWAY","NEM","PN","SEDG","ACMR","XOM","CVRX","RMD","ENPH","AU","VLO","SEZL","CVX","LTGO","MCHP","TRGP","XPOF","MB","FLR","RKT","TTD","STEP","EXFY","MTW","BETR","BLND","INVX","ABNB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":44,"code":"91000000","status":"200"}]}}